Aurobindo Pharma has informed that the Board of Directors of the Company at its meeting held on August 07, 2014, inter alia, has considered & approved Interim dividend of @150% i.e. Rs.1.50/- ( Rupee one and paise fifty only) per share of Rs. 1/- each on the equity shares capital of the Company for the year 2014-15.
The above information is a part of company’s filings submitted to BSE
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1876.85 |
| Dr. Reddys Labs. | 1346.95 |
| Cipla | 1460.60 |
| Zydus Lifesciences | 1117.10 |
| Lupin | 2405.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: